These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22890723)

  • 1. Glyco-engineering in plants to produce human-like N-glycan structures.
    Castilho A; Steinkellner H
    Biotechnol J; 2012 Sep; 7(9):1088-98. PubMed ID: 22890723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glyco-engineering of biotherapeutic proteins in plants.
    Ko K; Ahn MH; Song M; Choo YK; Kim HS; Ko K; Joung H
    Mol Cells; 2008 Jun; 25(4):494-503. PubMed ID: 18443408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioprospecting in plants for engineered proteins.
    Joshi L; Lopez LC
    Curr Opin Plant Biol; 2005 Apr; 8(2):223-6. PubMed ID: 15753005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled glycosylation of plant-produced recombinant proteins.
    Strasser R; Altmann F; Steinkellner H
    Curr Opin Biotechnol; 2014 Dec; 30():95-100. PubMed ID: 25000187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-translational modification of plant-made foreign proteins; glycosylation and beyond.
    Webster DE; Thomas MC
    Biotechnol Adv; 2012; 30(2):410-8. PubMed ID: 21839159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-glycosylation of plant-produced recombinant proteins.
    Bosch D; Castilho A; Loos A; Schots A; Steinkellner H
    Curr Pharm Des; 2013; 19(31):5503-12. PubMed ID: 23394562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Glyco-Engineering in Plants: Update on Strategies and Major Achievements.
    Steinkellner H; Castilho A
    Methods Mol Biol; 2015; 1321():195-212. PubMed ID: 26082224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyco-engineering of moss lacking plant-specific sugar residues.
    Huether CM; Lienhart O; Baur A; Stemmer C; Gorr G; Reski R; Decker EL
    Plant Biol (Stuttg); 2005 May; 7(3):292-9. PubMed ID: 15912449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using glyco-engineering to produce therapeutic proteins.
    Dicker M; Strasser R
    Expert Opin Biol Ther; 2015; 15(10):1501-16. PubMed ID: 26175280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic engineering of microorganisms for the synthesis of plant natural products.
    Marienhagen J; Bott M
    J Biotechnol; 2013 Jan; 163(2):166-78. PubMed ID: 22687248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glyco-Engineering Plants to Produce Helminth Glycoproteins as Prospective Biopharmaceuticals: Recent Advances, Challenges and Future Prospects.
    van der Kaaij A; van Noort K; Nibbering P; Wilbers RHP; Schots A
    Front Plant Sci; 2022; 13():882835. PubMed ID: 35574113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constructing a human complex type N-linked glycosylation pathway in Kluyveromyces marxianus.
    Lee MH; Hsu TL; Lin JJ; Lin YJ; Kao YY; Chang JJ; Li WH
    PLoS One; 2020; 15(5):e0233492. PubMed ID: 32469948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant glycans: friend or foe in vaccine development?
    Bosch D; Schots A
    Expert Rev Vaccines; 2010 Aug; 9(8):835-42. PubMed ID: 20673008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant-specific glycosylation patterns in the context of therapeutic protein production.
    Gomord V; Fitchette AC; Menu-Bouaouiche L; Saint-Jore-Dupas C; Plasson C; Michaud D; Faye L
    Plant Biotechnol J; 2010 Jun; 8(5):564-87. PubMed ID: 20233335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure.
    Shin YJ; Chong YJ; Yang MS; Kwon TH
    Plant Biotechnol J; 2011 Dec; 9(9):1109-19. PubMed ID: 21801300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells.
    Grabenhorst E; Schlenke P; Pohl S; Nimtz M; Conradt HS
    Glycoconj J; 1999 Feb; 16(2):81-97. PubMed ID: 10612409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering of glycosylation in yeast and other fungi: current state and perspectives.
    De Pourcq K; De Schutter K; Callewaert N
    Appl Microbiol Biotechnol; 2010 Aug; 87(5):1617-31. PubMed ID: 20585772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures.
    Bardor M; Loutelier-Bourhis C; Paccalet T; Cosette P; Fitchette AC; Vézina LP; Trépanier S; Dargis M; Lemieux R; Lange C; Faye L; Lerouge P
    Plant Biotechnol J; 2003 Nov; 1(6):451-62. PubMed ID: 17134403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-glycosylation engineering of biopharmaceutical expression systems.
    Jacobs PP; Callewaert N
    Curr Mol Med; 2009 Sep; 9(7):774-800. PubMed ID: 19860659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in therapeutic glycoprotein production.
    Sethuraman N; Stadheim TA
    Curr Opin Biotechnol; 2006 Aug; 17(4):341-6. PubMed ID: 16828275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.